The NUZ-001 arm of the HEALEY ALS trial is expanding enrollment to 240 participants. NUZ-001 is an experimental ALS therapy ...
Highlights: Montara Therapeutics awarded non-dilutive funding grant from The Michael J. Fox Foundation (MJFF) to advance a BrainOnlyâ„¢ therapy ...
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics of BY101298: Initial report from dose escalation cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...
Prognostic value of hedgehog signaling in cervical carcinoma. Background: Although improvements in the treatment of ovarian cancer have increased the global prognosis, the metastatic disease is still ...
Researchers in Japan found that lower plasma copper levels and reduced white matter volume in individuals with autism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results